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ABSTRACT

Crane, Miriam A. M.S., Department of Chemistry, Wright State University, 2019. In
vitro Uptake and Biodistribution of Silver Nanoparticles in Vero 76 Cells

The number of consumer products containing nanomaterials over the last eight years has
increased over two-fold. Silver is one of the most commonly used materials in consumer
goods nanoparticle fabrication.1 Thus, the uptake and biodistribution of silver
nanoparticles (AgNPs) within mammalian cells can provide insight into their possible
toxicological effects. In this study, starch-capped AgNPs of an average diameter of 9 ± 5
nm were synthesized via a bottom-up method, and characterized by Raman spectroscopy,
transmission electron microscopy (TEM), inductively couple plasma optical emission
spectroscopy (ICP-OES), and absorption spectroscopy. Vero 76 cells were incubated with
0.0, 0.1, 1.0, and 3.0 mg L-1 starch-capped AgNPs for 2, 4, 12, and 24 hr in a water
vehicle control for imaging with CytoViva darkfield microscopy and hyperspectral
analysis. It was observed that the morphology of the cells was negatively impacted at all
exposure concentrations in a dose-dependent manner. The cells appear clustered, had
fewer dendrites forming, and cell debris is visible on the microscope slide. Vero 76 cells
were exposed to all concentrations of AgNPs for 4 hr at 0.0, 0.1, 1.0, and 1.5 mg L-1 for
mitochondrial isolation and total Ag uptake was estimated by ICP-OES. It was
determined that at exposure concentrations of 1.0 and 1.5 mg L-1, AgNPs remained in the
incubated Dulbecco’s Modified Eagle Medium (DMEM), 86% and 77%, respectively. A
III

bicinchoninic acid (BCA) protein assay was also performed under similar conditions in
order to examine cell viability. Cellular toxicity was found to be concentration
dependent; the smallest cell viability value (7%) was observed at the highest
concentration of AgNPs (3 mg L-1).
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1. Introduction
1.1. Silver Nanoparticles (AgNPs)
1.1.1. Background of Silver Nanoparticles
According to the U.S. Environmental Protection Agency (EPA), a nanoparticle is
characterized as a particle with at least two dimensions within the range of 1 to 100 nm.2
The use of nanomaterials in everyday life seems unreal, yet they are found in consumer
goods from health and fitness to goods for children, as well as in the medical field
(Figure 1). This is largely due to nanoparticles having unique physicochemical
characteristics (PCCs) when compared to the bulk material. These PCCs are:
composition, size, size distribution, shape, surface area, surface chemistry, surface
charge, purity, aggregation state, solubility, stability, and surface reactivity.3 All of these
characteristics can be tailored during nanofabrication by means of the choice of reducing
agent and capping agent. According to the Consumer Product Inventory issued by The
Project on Emerging Nanotechnologies, the nanotechnology sector has vastly grown to
over a trillion dollars.4,5 With the growth of this industry, the possible impact of
nanoparticles on humans and the environment became an important topic of research and
discussion around the world.
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Figure 1. Total number of consumer goods containing nanomaterials by material (N =
383, N = 150, N = 123, N = 75, N = 73, N = 55, N = 43, N = 44, N = 46, N = 26, N = 26,
N = 25, N = 21, N = 19, N = 17, N = 13, N = 11, N = 10, N = 14, and N = 10,
respectively) and category. (Charts reconstructed by Miriam Crane from data in The
Nanodatabase)1

The most commonly used metal in the nanoparticle fabrication is silver. This is due to its
antimicrobial and antibacterial properties (Figure 1).6,7 Studies on Gram-positive and
Gram-negative bacteria show that AgNPs have inhibitory and bactericidal effects.8,9
Numerous in vivo and in vitro studies have found that AgNPs have cytotoxic and
genotoxic effects in both animal and human cell lines.10,11,12,13,14 While there is no EPA
standard limiting the amount of AgNPs within consumer goods, there is a limit set for
ionic silver in drinking water of 0.10 mg L-1 (i.e., the Secondary Maximum Contaminant

2

Level).15 Thus, the mechanism by which the AgNPs are causing cellular toxicity is of
great interest.
1.1.2. Common Fabrication Techniques of Nanoparticles
There are numerous fabrication methods for AgNPs, but two main techniques are topdown and bottom-up approaches (Figure 2).

Figure 2. Top-down and bottom-up approaches for nanoparticle fabrication.
The top-down technique is the process of taking a bulk material and breaking it down by
means of finer and finer tools to a smaller scale until the nanoscale level is reached. This
can be done by means of mechanicanosynthetic methods, thermal methods, and chemical
fabrication. Mechanicanosynthetic methods include ball milling by abrasion, compaction
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and consolidation, which are used to make nanocomposites. The mechanical top-down
methods are largely employed in industry because they are less expensive to scale-up to
production volumes. The thermal methods such as laser ablation, arc discharge, solar
flux, and plasma methods require an excessive high energy input; therefore, the potential
for scale-up and quality control are restricted. Top-down chemical fabrication methods
are widely utilized in industry because of the scale-up is easier to implement. Other
chemical fabrication methods commonly exploited in industry include anodizing,
lithography, and nanoimprint lithography.
The bottom-up technique starts at the atomic or molecular level and is driven by a natural
physical property or an applied external force to give rise to larger, more organized
systems. Chemical vapor deposition, atomic layer deposition, and molecular beam
epitaxy are used in industry. Electrodeposition and electroless deposition are simple ways
to manufacture various forms of nanomaterials. Numerous liquid phase methods are low
cost and can be scaled-up.16 Thus, the liquid phase method is selected for the fabrication
of AgNPs in this thesis.
1.1.3. Background on Starch-Capped AgNPs
As mentioned above, a liquid phase method was selected to fabricate starch-capped
AgNPs. The cytotoxicity and genotoxicity of these AgNPs have been studied in
zebrafish, human cells, and bacteria models, just to name a few.10, 17 This is a green
method for nanomaterials fabrication as it uses nontoxic reducing/capping agent(s),
environmentally benign solvents, and/or renewable materials. The reducing/capping
agent in this thesis work is a soluble polysaccharide, namely potato starch (Figure 3).
This reducing/capping agent is nontoxic, environmentally friendly, and widely available.
4

In a previous study, starch alone (2.8% w/v) was found to have no cytotoxic effect in
normal human lung fibroblasts and human glioblastoma cells, thus confirming its
biocompatibility.11 Amylose is a soluble starch, which in aqueous solutions forms a lefthanded helical conformation chain with linkages α (1→4) between D-glucose
subunits.17,18

α1
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Figure 3. Depiction of the structure of amylose chain formed by the α (1-4) linkages
between D-glucose subunits (Structure made via ChemDoodle).
Due to its conformation in water, starch behaves as a linear polymer by forming films and
complexes with ligands. The theorized mechanism of reduction of silver nitrate is by its
reaction to the terminal aldehyde of the starch and stabilization of the nanoparticle by the
starch itself.19
1.2. Mammalian Cell Biology Background
Mammalian cells are eukaryotic cells; this means that the cell contains organelles that
carry out specialized functions. Each organelle is bound by a membrane, which controls
the flow of molecules and ions into/out of the cell and thereby maintains its specialized
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environment. The structure of a mammalian cell and the various types of organelles are
displayed in Figure 4.

Figure 4. Depiction of a mammalian cell with its various organelle labeled (purchased by
Miriam Crane on stockphotos.com; Order # 73684).

Briefly, the main organelles of mammalian cells are the endoplasmic reticulum (ER),
Golgi body, ribosomes, nucleus, centriole, mitochondrion, plasma membrane, and
cytoskeleton. The ER, Golgi body and ribosomes are composed of polypeptide chains
and lipids. The cytoskeleton contributes to cell shape and movement, where the plasma
membrane selectively controls what moves in and out of the cell. The centrioles are
associated with cell division. The nucleus houses, protects, and controls access to the
deoxyribonucleic acid (DNA). Mitochondria are responsible for key stages of cellular
respiration, including the citric acid cycle and oxidative phosphorylation. It is the main
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site for adenosine triphosphate (ATP) production, which provides the energy source for
the cell. Understanding the interactions between AgNPs and mitochondria will give
insight into key toxic effects.
Mammalian cells undergo a process called endocytosis to ingest nutrients, fluids, and
other molecules needed for survival (Figure 5).20

Figure 5. Macromolecules being internalized by the process of endocytosis. (Figure
courtesy of SERVIER Medical Art, https://smart.servier.com/)
Macromolecules are internalized by the plasma membrane surrounding the nutrients,
which buds off inside the cell forming what is called a vesicle. Once the macromolecule
is inside the cell, catabolism, i.e., the degradation of complex molecules into simpler ones
by means of enzymatic breakdown, takes place in lysosomes. Digestion of the
macromolecule into its subunits allows for the cell to utilize them for glycolysis (derived
from the Greek words glykys, “sweet”, and lysis, “splitting”), which takes place in the
cytosol. The next two stages of cellular respiration, the citric acid cycle and oxidative
breakdown, happen solely in the mitochondria.21
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1.2.1. Structure and Function of Mitochondria
As mentioned previously, mitochondria of a cell are the main site for energy production
in the form of ATP, which is produced through cellular respiration. Figure 6 displays the
structural components of a mitochondrion.

Matrix
Ribosome

Intermembrane space

Inner membrane

ATP synthase
(F0F1 portion)
Mitochondrial DNA

Outer membrane

Cristae

Figure 6. Representation of a mitochondrion and its specific parts (purchased by Miriam
Crane on stockphoto.com; Order 106975).

The mitochondrion has four separate compartments within its structure: outer membrane,
inner membrane, matrix, and intermembrane space. A unique set of proteins can be found
in each compartment that enable it to perform its function. Both the outer and inner
membrane are composed of phospholipid bilayers with their unique set of proteins
imbedded into them. The outer membrane contains channel-forming proteins called
porin, which form wide aqueous channels through the lipid bilayer and make the
membrane permeable to molecules less than 5,000 Daltons. The inner membrane is
highly folded into cristae, which contain proteins to carry out oxidation reactions during
the electron-transport chain on the membrane and ATP synthase that produces ATP
8

molecules within the matrix of the mitochondrion. The inner and outer membranes form
an intermembrane space between the two of them; this contains several enzymes that use
the ATP passing out of the matrix to phosphorylate other nucleotides. The matrix is
comprised of a highly concentrated mixture of enzymes required for oxidative reactions
as well as other metabolic pathways. All these compartments play a key role in the citric
acid cycle and the electron transport chain (i.e., oxidative phosphorylation). Figure 7
depicts two key parts of cellular respiration: the electron transport chain and the citric
acid cycle.21

Figure 7. Depiction of the citric acid cycle and the membrane-based mechanism of the
electron-transport chain of mitochondria. (Figure constructed with images courtesy of
SERVIER Medical Art, https://smart.servier.com/)
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The first part of cellular respiration, glycolysis, takes place in the cytosol of the cell and
breaks down simple subunits to pyruvate. Pyruvate is pumped into the mitochondrial
matrix, where it undergoes decarboxylation by three enzyme complexes (the pyruvate
dehydrogenase complex) to produce reduced nicotinamide adenine dinucleotide
phosphate (NADH), carbon dioxide (CO2), and acetyl Coenzyme A (CoA). Acetyl CoA
then enters the citric acid cycle where it undergoes oxidative breakdown to form NADH
and flavin adenine dinucleotide (FADH2). Both NAD+ and FAD are important highenergy electron carriers, in their reduced form they carrier electrons and hydrogen.
NADH and FADH2 transfer the electrons to the last step in the oxidation of nutrients: the
electron transport chain. This is the step in which most chemical energy of a cell is
produced in the form of ATP. The electron transport chain is a membrane-based
mechanism, meaning the complexes are embedded within the phospholipid bilayer of the
inner membrane of the mitochondrion. Ions are transported across the membrane by four
protein complexes; the electron transfers release energy used to pump protons (H+) from
omnipresent water within the cell across the membrane generating an electrochemical
proton gradient. The H+ flow back into the matrix through a protein complex called ATP
synthase, which catalyzes the energy required for the synthesis of ATP from adenosine
diphosphate (ADP) and inorganic phosphate. If the metabolic reactions and processes are
interrupted, this can cause the cells’ ATP content to drop, meaning possible apoptosis
(cell death) could occur.21
1.3. Background on Vero 76 Cell Line
The biological matrix chosen for this project was Vero 76 cells, which were derived from
a kidney of a normal adult African Green monkey (Cercopithecus aethiops) in the 1960s.
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This cell line is well established in continuous mammalian cell research. The
characteristics of this cell line are that they are anchorage-dependent, dendritic, and must
be cultured before 100 % confluency (amount of cell culture dish covered by cells) is
reached or cell death will occur.22 Figure 7 displays an image of the cells at
approximately 70 % confluency, note the dendric shape. These dendrites allow for the
cells to communicate.
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Figure 8. Optical image of a monolayer of Vero 76 cells grown to ~ 70 % confluency.

1.4. Knowledge Gaps
The biomedical applications of AgNPs are limited by the lack of well-established
methodologies for studying their cellular translocation and possible transformations.
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1.5. Main Goal and Specific Aims
Main Goal:
Quantify total silver absorbed by whole Vero 76 cells and their mitochondria via ICPOES and follow silver nanoparticle distribution by hyperspectral CytoViva imaging. It is
thought that as concentration exposure of AgNPs and time of incubation are increased,
the cytotoxic effects will increase.10,17
Specific Aim 1:
Synthesize, purify, and characterize starch-capped AgNPs via centrifugation and
tangential flow filtration (TFF), ultraviolet and visible absorption spectroscopy (UV-Vis),
transmission electron microscopy (TEM), CytoViva hyperspectral microscopy, Raman
spectroscopy, and inductively coupled plasma-optical emission spectroscopy (ICP-OES).
Specific Aim 2:
Isolate and determine total cellular protein content of whole Vero 76 cells and their
mitochondria before and after exposure to colloidal AgNPs via a mitochondrial isolation
assay.
Specific Aim 3:
Quantify the total silver content within these biological matrices by ICP-OES and
monitor nanoparticle distribution by hyperspectral CytoViva imaging.
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2. Method

2.1. Chemicals and Materials
Silver nitrate (> 99%, solid, AgNO3) was manufactured by Acros Organics. A trace metal
grade ICP-OES silver standard (1.00 x 103 mg L-1) was purchased from CentraPrep. Trace
metal grade nitric acid (70%, TM HNO3) and soluble starch (powder, C12H22O11) were
acquired from Fisher Scientific. All chemicals and reagents were used as received,
without any further purification. High quality water (> 18 MΩ cm, HQ H2O) was utilized
as a solvent.
Vero 76 cells (ATCC® CRL #1587TM) were procured from American Type Culture
Collection. Dulbecco's Modified Eagle's Medium/High Glucose (DMEM), penicillinstreptomycin glutamine (100x, PS), and trypsin (0.05%) with EDTA (0.53 M) were
obtained from HyClone. Fetal bovine serum (FBS) was purchased from Corning.
Phosphate buffered saline (1x, PBS), hydrogen peroxide (30%), and formaldehyde (37%)
were acquired from Fisher Bioreagents. MitoTracker red CMXRos (MT red) was attained
from Invitrogen. Mitochondrial isolation kit and bicinchoninic acid (BCA) protein assay
were manufactured by Thermofisher.
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2.2. AgNP Synthesis and Purification
2.2.1. Synthesis and Purification via Centrifugation
Starch-capped AgNPs were synthesized by a one-pot green synthesis method in an
autoclave bottle.19 Briefly, 1.0 g of soluble starch was dissolved through heating in 100
mL of HQ H2O on a hot plate at ~ 90° C for ~ 1 hr. Afterward, 1 mL of AgNO3 solution
(100 mM) was added all at once and mixed through manual stirring. The resulting
mixture was immediately autoclaved at 15 psi and 121 °C for 20 min. The resulting
colloid was light-yellow in color (Figure 9A), which confirmed the formation of AgNPs.
After cooling to room temperature, the colloid was passed through a 0.2 μm syringe filter
(Figure 9B). The colloid was then centrifuged at 14,000 rpm (22,789 g) for 1 hr and the
resulting pellet containing AgNPs was washed twice with HQ H2O through similar
centrifugation in order to remove excess starch (Figure 9C-9E). AgNPs collected at each
step of the centrifugation process in the pellet were redispersed through ultrasonication
(output power of 25-43 Watts) for ~ 20 to 30 s into fresh HQ H2O. The purified colloid
maintained its characteristic light-yellow color (Figure 9F) and was filtered after a 24 hr
stabilization period.
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A

B

C

D

E

F

Figure 9. Image of original colloid (A), 0.2 μm permeate (B), supernatant (C), wash #1
supernatant (D), wash #2 supernatant (E), and redispersed pellet for TFF process (F).
2.2.2. Size-Selection, further Purification, and Concentration via Tangential Flow
Filtration (TFF)
The TFF process was applied as described in literature.23 In this study, the size selection,
further purification, and concentration of the centrifuged AgNPs colloid (80 mL) was
achieved manually through a one-step tangential filtration (Scheme 2.1) with a 70 kD
modified polyetherethersulfone Midi Kros filter module (115 cm2, > 10 nm pore size, from
Spectrum Labs, Inc.) and polypropylene syringes for sample injection (Figure 10A). The
final 70 kD retentate of starch-capped AgNPs maintained its characteristic color (Figure 10B)
and was used in cell experiments within one week from filtration.
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Scheme 2.2-1. Flow diagram for tangential flow filtration of AgNPs.
Original colloid

Retentate

70 kD
> 10 nm

= AgNPs of various
sizes
= Water
= Ag+ and excess
reagents

Permeate

A
Inlet/Retentate
collection

Inlet/Retentate
collection

B
Permeate Collection

Figure 10. Image of the TFF setup (A) and the final 70 kD retentate of AgNPs for cellular
experiments (B).
2.3. AgNPs Characterization
Ultraviolet and visible (UV-Vis) absorption spectroscopy, inductively coupled plasma
optical emission spectroscopy (ICP-OES), Raman spectroscopy, Transmission Electron
Microscopy (TEM), and CytoViva Hyperspectral microscopy were employed for the
characterization of the concentrated AgNP colloid.
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2.3.1. Ultraviolet and Visible (UV-Vis) Absorption Spectroscopy
A Varian Cary 50 Bio UV-Vis spectrophotometer was utilized to collect the absorption
spectra of colloidal samples (200-800 nm) in disposable cuvettes (1 cm optical path), at a
fast scan rate (spectral resolution of 1 nm). Absorption readings in the UV-range, a quartz
cuvette (1 cm optical path) was utilized. All spectra were baseline corrected with respect
to water before analysis in Origin 8 software.
2.3.2. Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES)
In preparation for ICP-OES measurements, an acid digestion was performed on all
colloidal samples of interest. A 10 μL sample aliquot was added to 5 mL of TM HNO3 at
room temperature and allowed to cold digest for 10 min. The sample was then heated on
a hot plate at ~ 275° C to evaporate the acid solvent, until approximately 10 μL of sample
remained. Once cooled to room temperature, the sample was quantitatively rinsed into a
10 mL volumetric flask with 286 μL of TM HNO3 to a final 2% HNO3 matrix. An
external calibration was performed using 10 standards ranging from 0 – 350 μg L-1,
which were made from an ionic silver standard (1,000 mg L-1) by quantitative dilutions in
2% HNO3 acid matrix.
ICP-OES analysis was performed on a Varian 710-ES system under the following
operating conditions: wavelengths of 328.068 nm and 338.289 nm for silver emission,
plasma flow of 15.0 min-1, auxiliary flow of 1.50 L min-1, and radio frequency power of
1.2 kW. Samples were measured in triplicate with a replicate acquisition time of 15 s, an
internal stabilization time of 40 s, and an uptake delay time of 45 s.
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2.3.3. Raman Spectroscopy
Colloidal samples were placed into a 2 mL quartz cuvette (1 cm optical path) to collect
their Raman spectra on a Horiba LabRam HR800 Raman spectrometer with an excitation
line of 532 nm from a Nd: YAG green internal laser (15 mW output). Data was collected
from 100-4000 cm-1, utilizing the confocal Raman BX41 microscope, Olympus 100x and
50x objectives, a confocal hole of 300 μm, a holographic grating of 600 grooves mm-1,
and a thermoelectrically cooled Andor CCD camera (1024 x 256 pixels). The acquisition
times and number of cycles were 3 s and 3, respectively. The spectral resolution in each
measurement was ~ 1 cm-1. Data was collected on LabSpec v.5 software and analyzed
using Origin 8 software.
2.3.4. Transmission Electron Microscopy (TEM)
A 5 μL colloidal sample was drop casted onto a 300-mesh copper grid equipped with a
lacey carbon support film and allowed to sit at room temperature for 24 hr in a desiccator
for subsequent drying. AgNP samples were analyzed on a Philips EM 208S TEM coupled
to a high resolution Gatan Bioscan camera; all images were captured under a 70-kV
electron beam. ImageJ and Origin 8 software were employed for particle analysis and
size distribution plots, respectively.
2.3.5. CytoViva Hyperspectral Imaging
A 5 μL sample was placed onto a glass microscope slide, covered with a microscope
coverslip, and allowed to air dry for 15 to 20 min, then sealed with clear nail polish.
Images were collected with 10x air, 60x and 100x oil immersion objectives on an
Olympus BX 53 CytoViva enhanced dark field microscope and the Ocular software. The
ENVI software was employed for the hyperspectral data collection with exposure time
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varying from 0.5–1.0 seconds and 696 x 696 pixels. Data was analyzed using Origin 8
software.
2.4. Preparation and Analysis of Vero 76 Cells
2.4.1. Culture cells
Adherent Vero 76 cells were grown in 100 mm petri dishes, in complete growth media
made up of 89% DMEM, 10% FBS, and 1% PS. The cells were incubated at 37° C in a
5% CO2 environment and were cultured to ~ 75% confluency before splitting or counting.
2.4.2. Total Cellular Protein Determination
Colorimetric detection and quantitation of total protein within a sample for the purpose of
determining percent of viable cells was performed via a bicinchoninic acid (BCA) assay
kit. A set of 9 external calibration standards ranging from 0 – 2,000 mg L-1 were prepared
from a bovine serum albumin stock of 2 g L-1 by quantitative dilutions in 1x PBS. Cells
were harvested by trypsinization with 10 mL of trypsin for 4 min and subsequent
centrifugation at ~1,243 rpm (630 g) for 10 min. The supernatant was removed, and the
cell pellet was redispersed into 2 mL of 1x PBS. This was followed by the addition of 2
mL of NaOH solution (1 mM) for lysing purposes. The standards and cell samples of
interest (25 µL of each) were then placed in a 96-well plate and 200 µL of a proprietary
reagent mix (50:1 ratio of Reagent A to Reagent B) was added to each well. After
incubation at 37 °C for 30 min in the cell incubator, the light absorbance was measured at
562.0 nm via a Varian Cary 50 microplate reader extension of the Varian Cary 50 Bio
UV-Vis spectrophotometer. Total cellular protein content was determined before and
after exposure to AgNPs.
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2.4.3. Staining with MT-red, Exposure to AgNPs, and Fixing Cells for CytoViva
Hyperspectral Microscopy
Vero 76 cells were grown on glass coverslips in 35 mm petri dishes for 12-24 hr prior to
staining with MT-red. Two milliliters of 150 nM MT-red dye were added and incubated
at 37° C in a 5% CO2 environment for 30 min. Residual dye was removed by washing
three times with 1x PBS solution. Cells were then exposed to varying final well
concentrations (0, 0.1, 1, and 3 mg L-1) of AgNPs and incubated at 37° C in a 5% CO2
environment for 2, 4, 12, and 24 hr. After exposure to AgNPs, the cells were washed
three times with DMEM, followed by three washes of 1x PBS to remove any residual
AgNPs. Cells were then fixed in a 3.7% formaldehyde solution that was pipetted directly
onto the coverslip and allowed to sit for 20 min in the dark. The cells were then washed
three times with 1x PBS to remove any residual formaldehyde. A drop of 1x PBS was
pipetted onto a clean glass microscope slide, the coverslip was placed onto the slide, and
sealed with clear nail polish. The analysis parameters were the same as stated above
(Section 2.3.4). Fluorescence emission analysis was also performed using a triple pass
filter and a Prior Lumen 200 light source. Data was processed using GIMP and Origin 8
software.
2.4.4. Preparation of ICP-OES samples
Vero 76 cells were grown in tissue culture flasks (surface area175 cm2) until ~ 75%
confluent. Cells were then exposed to various concentrations (0, 0.1, 1, and 1.5 mg L-1) of
AgNPs and incubated at 37° C in a 5% CO2 environment for 4 hr before harvest. The
AgNP containing media was first removed by pipet and a sample aliquot was saved for
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further analysis. The plate was then washed with PBS (1x) to remove any residual
AgNPs; all washings were saved for analysis.
Approximately 10 mL of trypsin was added to the T-flask and incubated for 4 min at 37°
C in a 5% CO2 environment. Trypsin cleaves the proteins that are responsible for
adhering the Vero 76 cell to the plate. After 4 min, the plate was removed from the
incubator and 40 mL of fresh media was added to the plate to inhibit the trypsin. The cell
suspension was pipetted up and washed down the flask three times, then pipetted up and
down a total of six times, with a final washed down to ensure the cell suspension was
thoroughly mixed. The cell suspension was centrifuged at ~1,243 rpm (630 g) for 10 min
to obtain a cell pellet. The supernatant was pipetted off and saved for ICP-OES analysis.
The pellet was then used for mitochondrial isolation.
Mitochondrial isolation was performed by means of a mitochondrial isolation kit for
cultured cells. The pellet was redispersed in 2 mL of DMEM and transferred to a 2 mL
micro-centrifuge tube. The cell suspension was centrifuged at 3,057 rpm (900 g) for 2
min to repellet the cells. The supernatant was then removed, and reagent A (800 μL) was
added. The pellet was vortexed at 1,500 rpm (6 g) for 5 seconds and incubated on ice for
2 min. Reagent B (10 µL) was added, and vortexed at 3,000 rpm (25 g) for 5 seconds.
The cell suspension was incubated on ice for 5 min while vortexed at 3,000 rpm (25 g)
every minute. Reagent C (800 µL) was added to the cell suspension, the tube was
inverted several times followed by centrifugation at 2,696 rpm (700 g) for 10 min. The
supernatant was then transferred to a new 2 mL micro-centrifuge tube and centrifuged at
3,530 rpm (12,000 g) for 15 min. The resulting supernatant was removed by pipetting.
Reagent C (500 µL) was then added to the pellet and centrifuged at 3,530 rpm (12,000 g)
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for 5 min. The supernatant was removed leaving the isolated mitochondria pellet. The
isolated mitochondria were redispersed in 2 mL of 1x PBS, and vortexed until
homogeneous. Aliquots were collected at each step in the mitochondrial isolation for
ICP-OES analysis. The ICP-OES samples were prepared via the method described above,
apart from 2 mL of 30% hydrogen peroxide for bleaching purposes prior to evaporating
the sample with heat. The analysis parameters were the same as stated above (Section
2.3.2).
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3. Results and Discussion
3.1. Characterization of AgNPs
In order to confirm the presence of AgNPs in the original colloid, UV-Vis absorption
spectroscopy was performed on all supernatants associated with the centrifugation
process and the TFF products. Absorption spectra of the original colloid, 0.2 μm filtrate,
supernatant/washes of pellet and the final 70 kD retentate AgNPs are shown in Figure 11.

Figure 11. UV-Vis absorption spectra of original colloid, 0.2 μm permeate,
supernatant/wash of pellet and diluted 70 kD retentate (1:10) showing the characteristic
Surface Plasmon Resonance peak (SPR) peak of AgNPs.
The present of the Surface Plasmon Resonance (SPR) peak at 413 nm confirms the
formation of colloidal AgNPs. The SPR peak suggests the AgNPs are spherical in shape.
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The characteristic SPR peak was maintained throughout the centrifugation and TFF
manipulation processes. A small shift in the SPR peak (411 nm) was seen after the TFF
process was applied. This is probably an indication of the reduction in the average size of
AgNPs after filtration as a result of the removal of larger AgNPs or AgNPs-aggregates.
To confirm excess starch was removed during the centrifugation process, UV-Vis was
performed on all supernatants associated with the centrifugation process, the 70 kD
retentate TFF product, and a 1% starch solution for comparison (Figure 12).

Figure 12. UV-Vis absorption spectra of 1% starch solution, original colloid, 0.2 µm
filtrate, supernatant/washes, and diluted 70 kD retentate (1:20) starch-capped AgNPs
showing the removal of starch throughout the centrifugation and TFF processes.

The 1 % starch solution had an absorbance greater than 1, but it is seen that starch
absorbs in the UV range. The spectrum corresponding to the original starch-capped
AgNPs, after the SPR peak, has an absorption in the UV range characteristic to starch.
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After the centrifugation process, the profile of the UV-vis spectrum of the 70 kD retentate
starch-capped AgNPs profile changes in the UV region, and the SPR remains the same,
this is indicative of excess starch being removed from the colloid. The supernatant of
wash 1 absorbs in the UV range, consistent with the characteristic spectra of starch,
confirming excess starch was removed.
To confirm that the filtered colloid was pure and free of excess reagents, Raman
spectroscopy was performed on the 70 kD retentate. The Raman spectrum of the final 70
kD retentate of starch-capped AgNP colloid is shown in Figure 13.

Figure 13. Raman spectrum of 1% starch solution and diluted 70 kD retentate starchcapped AgNP colloid showing characteristic peaks corresponding to water, thus
confirming purity.

The observation of peaks characteristic to water confirmed the purity of colloid. The
smallest peak at ~1651 cm-1 corresponds to the - OH bending mode, the shoulder at
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~3255 cm-1 is due to the symmetric - OH stretch, and the most intense feature at ~3384
cm-1 results from the asymmetric - OH stretch.24 The Raman spectrum for the 1% starch
solution utilized for the reduction and capping of the AgNPs is shown for comparison. It
should be noted that two peaks below 1000 cm-1 are in both spectra, this might be due to
the starch.
In order to determine the concentration of the AgNPs colloid, ICP-OES measurements
were performed on the original colloid and the aliquot samples collected at every step of
the centrifugation and TFF processes. The 10-point external calibration curve used for
ICP-OES analysis is displayed in Figure 14.

Figure 14. A representative ICP-OES 11-point external calibration curve together with
the interpolation equation and R2 value used to determine the total silver content in each
sample.
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Table 1 summarizes the ICP-OES results. It can be noted that AgNPs were lost in the
supernatant during the centrifugation process. Approximately 325 mL of the original
colloid of AgNPs was centrifuged, which resulted in ~ 80 mL of pellet containing
AgNPs. The pellet was filtered through a 70 kD TFF filter, and ~ 5 mL of final colloid
was attained.
Table 1. Total silver concentration of each colloid/supernatant throughout the
centrifugation and TFF processes were determined via ICP-OES.
Ag Concentration (mg L-1)
104
110
108
9
6
156

Sample
Original colloid
0.2 µm filtrate
Supernatant of pellet
Supernatant of wash 1
70 kD permeate
70 kD retentate

To confirm the morphology and size-distribution of the starch-capped 70 kD retentate
AgNPs, TEM was performed (Figure 15). It can be seen the starch-capped AgNPs are
spherical in shape; as they can be visualized as darker black silver cores embedded in a
lighter grey starch matrix. This was further confirmed by CytoViva images collected on
the AgNP samples before (Figure 17A) and after (Figure 17B) purification through
centrifugation and TFF.
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Figure 15. TEM micrograph of 70 kD retentate starch-capped AgNPs confirming
morphology and size distribution.

Multiple TEM micrographs were utilized to create a histogram (N = 335) in ImageJ
software (Figure 16). It was determined that the size distribution ranged from 4 nm to 24
nm with an average size of 9 ± 5.6 nm.
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Average size = 9 ± 5.6 nm

Figure 16. Histogram of particle size distribution (N = 335 AgNPs) compiled from TEM
micrographs.

After confirming size and shape via TEM, CytoViva images and hyperspectral data were
obtained on the 70 kD retentate starch-capped AgNPs (Figure 17). Spectra of the
different colored AgNPs were collected (N = 30). This gives a spectral fingerprint and
allows for the determination if the AgNPs are entering the cell and its organelles.
Hyperspectral data were collected before and after the centrifugation/TFF processes to
compare the spectral fingerprints.
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25 µm

Figure 17. Characteristic CytoViva images of A) original starch-capped AgNP colloid, C)
averaged hyperspectral of original starch-capped AgNP colloid, B) final 70 kD retentate
starch-capped AgNPs and D) averaged hyperspectral of 70 kD starch-capped AgNPs
used for cellular experiments (N = 30).
The full width half maximum values for the different colored AgNPs were calculated
(Table 2).
Table 2. Surface plasmon resonance maxima and full width half maximum values of
different colored AgNPs.
AgNP Sample
Blue
Green
Red

Maximum
Wavelength (nm)
497
549
619
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FWHM
187
184
170

3.2. Determination of Total Cellular Protein Content
The total cellular protein content determines the percentage of viable cells before and
after exposure to AgNPs. A calibration curve was constructed from absorbance readings
at 562 nm versus known concentrations of bovine albumin (Figure 18). This assay is
employing the biuret reaction, which is the reduction of Cu+2 to Cu+1 by a protein in an
alkaline medium and demonstrates a strong absorption at 562 nm.

Figure 18. A representative absorbance 9-point external calibration curve together with
the interpolation equation and R2 value used to determine the total cellular protein
content in each sample.
Utilizing the calibration curve made by serial dilutions from a 2 mg mL-1 bovine albumin
standard, the total cellular protein content at each exposure concentration was determined
by interpolation (Table 2).
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Table 3. BCA assay data of total cellular protein content for each 4 hr exposure to AgNPs
and vehicle control.
AgNP Exposure Concentration Total Cellular Proteins Percentage of Viable Cells
(mg L-1)
(µg mL-1)
(%)
Vehicle Control
2600 ± 600
51
0.0
5100 ± 300
100
0.1
1100 ± 100*
21
1.0
1600 ± 200*
32
1.5
2300 ± 300*
46
3.0
400 ± 50
7
* No significant mean difference from each other (P = 0.2).
The total cellular protein content at 0.0 mg L-1 of AgNPs was 5100 µg mL-1, which will
be referred to as 100% viable cells. The vehicle control alone (2.2 mL of HQ H2O in 47.8
mL of DMEM) reduced the number of viable cells by 49 % meaning that the amount of
water added to the cells induced lysing. Despite the vehicle control having adverse effects
on the cell population, a trend can still be seen with the addition of AgNPs. Exposure to
0.1, 1, 1.5, and 3 mg L-1 of AgNPs caused 79%, 68%, 54%, and 93% of viable cells to
die, respectively. If the percent of the dead cells associated with the vehicle control (2.2
mL of HQ H2O for each exposure) is subtracted from these percentages corresponding to
AgNP exposures, 30%, 19%, 5%, and 43% of cell death was caused by 0.1, 1.0, 1.5, and
3.0 mg L-1. More cell death occurred at lower concentrations, except at the highest
concentration (3 mg L-1). The effect of the vehicle control along with the AgNPs may be
responsible for the higher cell deaths at exposure concentrations. At an exposure level of
3 mg L-1 of AgNPs, there was only 7% of viable cells. Thus, the mitochondrial isolation
could not be performed at this exposure concentration. It would be expected that the
percentage cell viability would decrease with increasing exposure concentrations. A oneway ANOVA was run to determine if there was any significant difference between the
concentration exposures of 0.1, 1.0, and 1.5 mg L-1. Based on a p-vale of 0.20, there is
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not enough evidence to suggest there is a significant mean difference between any of the
three concentrations. The trend seen in the data was not what was hypothesized, this
might be because only three experiments were performed at each AgNP exposure
concentration. Another reason for the trend in the data might be attributed to cellular
growth. Even though the cell lines were all cultured under the same conditions, some may
have differed in growth rate, leading to a different number of cells in each exposure plate.
3.3. Imaging of Exposed Vero 76 Cells via CytoViva Hyperspectral Microscopy
Exposed Vero 76 cells were imaged via CytoViva Hyperspectral Microscopy in order to
observe the biodistribution of AgNPs within the cells. Cellular morphological changes
were observed as a result of the AgNP exposure. All CytoViva samples were stained with
MT-red to examine possible mitochondrial changes associated with the AgNP exposures.
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Figure 19. CytoViva optical images overlaid with fluorescence images of exposed Vero
76 cells after exposure to a) 0, b) 0.1, c) 1.0, and d) 3.0 mg L-1 of starch-capped AgNPs
for 2 hr. All cells were stained with 150 nM of Mito-tracker red dye prior to AgNP
exposure. All scale bars are 25 µm.

Figure 19 displays the CytoViva optical images of cells superimposed on the
corresponding fluoresence images after 2 hr exposure to various concentrations of
AgNPs. In Figure 19a, the control image (0 mg L-1) displays a healthy cell. It should be
noted that these control cells exhibited normal the dendridic features and an even
distribution of mitochondria throughout the cytoplasm. After exposure to 0.1 mg L-1 for 2
hr (Figure 19b), the mitochondria were no longer dispersed evenly within the cytoplasm.
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As the exposure concentration increased, this trend increased as well. The morphology of
the cell drastically changed with the increase of exposure concentration. In Figure 19c
and Figure 19d, the cell shape is no longer smooth in appearance and looks compromised.
These obsevations suggest that these cells might be in different stages of cell death.
Figure 20 is comprised of the corresponding hyperspectral data for the above mentioned
AgNP exposure concentrations at 2 hr. Data from all AgNPs seen on the cell were
collected and then averaged in Origin.

a

b

c

Figure 20. Corresponding hyperspectral data of Vero 76 cells exposed to a) 0, b) 1.0, and
c) 3.0 mg L-1 of AgNPs for 2 hr.

The control cell (0 mg L-1) was observed to have a peak at 559 nm (Figure 20a). This
spectral signature for the control remained constant at all exposure times. At 1 mg L-1
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exposures of AgNPs, it was observed that the spectral fingerprint widens ever so slightly
(Table 4). This suggests that the AgNPs are interacting with the cell at the 1 mg L-1
AgNP exposure.
Table 4. Spectra maxima and full width half maximum of cell and AgNPs at each
exposure concentration for 2 hr.
AgNPs Exposure
Concentration (mg L-1)
0
1
3

Maximum Wavelength
(nm)
559
581
555

FWHM
219
221
190

At 3 mg L-1 AgNP exposure, the peak obtained by averaging all AgNPs together, was
narrower than the FWHM of the 0 mg L-1 control cell, but broader than any of the
hyperspectral AgNPs. Thus, suggesting AgNPs are interacting with the cell.
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Figure 21. CytoViva optical images overlaid with fluorescence images of exposed Vero
76 cells after exposure to a) 0, b) 0.1, c) 1.0, and d) 3.0 mg L-1 of starch-capped AgNPs
for 4 hr. All cells were stained with 150 nM of Mito-tracker red dye prior to AgNP
exposure. All scale bars are 25 µm.
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Figure 21 displays the CytoViva optical images of cells superimposed on the
corresponding fluorescence images after 4 hr exposure to various concentrations of
AgNPs. Figure 21a displays the image of a healthy cell and even mitochondrial
distribution. At an exposure concentration of 0.1 mg L-1 of AgNPs for 4 hr, the cell
membrane appears rough, almost oval in shape, and cell debris was observed on the slide.
As the exposure concentration was increased, the amount of cell debris on the slide
increased and finding a fixed cell for imaging became more difficult. Figure 22 displays
the corresponding averaged hyperspectral data for the various concentrations of AgNPs at
the exposure time of 4 hr. Data from all AgNPs seen on the cell were collected and then
averaged in Origin.

a

b

Figure 22. Corresponding hyperspectral data of Vero 76 cells exposed to a) 1.0, and b)
3.0 mg L-1 of AgNPs for 4 hr.
Figure 22a and 22b, suggest interaction of AgNPs with the cells at exposure
concentrations of 1.0 and 3.0 mg L-1. This can be concluded based on the shifts in peak
position and peaks FWHM (Table 5). The control cell peak corresponding to the 4 hr
exposure to AgNPs was similar to the one after 2 hr exposure.
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Table 5. Spectra maxima and full width half maximum of cell and AgNPs at each
exposure concentration for 4 hr.
AgNPs Exposure
Concentration (mg L-1)
0
1
3

Maximum Wavelength
(nm)
559
554
587

FWHM
219
188
201

At the 1 mg L-1 AgNP exposure concentration, the FWHM was narrower than that of the 0
mg L-1 control cell, but wider than the FWHM of the AgNPs alone. This suggests there is
interaction between the AgNP and the cell. The same observation was made at the 3
mg L-1 AgNP exposure concentration.
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Figure 23. CytoViva optical images overlaid with fluorescence images of exposed Vero
76 cells to a) 0, b) 0.1, c) 1.0, and d) 3.0 mg L-1 for 12 hr. All cells were stained with 100
nM Mito-tracker red dye prior to AgNP exposure. All scale bars are 25 µm.
Figure 23 displays the CytoVivia optical images of cells superimposed on the
corresponding fluoresence images after 12 hr exposure at various concentrations of AgNPs.
With increased exposure time, the toxicological effects of the AgNPs can clearly be
observed. As the concentration was increased for this exposure time, the cell morphology
was negatively impacted indicating cytotoxicity. At the highest exposure concentration of
3 mg L-1 of AgNPs, the cells were deformed. Furthermore, fluoresence images could not
be collected to the the large amount of cell debris present on the slide at this concentration.
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Figure 24 displays the corresponding hyperspectral data for the mentioned 12 hr exposures
conditions.

a

c

b

Figure 24. Corresponding hyperspectral data of Vero 76 cells exposed to at a) 0.1, b) 3.0,
and c) 1.0 mg L-1 of AgNPs for 12 hr.
These hyperspectral data of all exposure concentrations of AgNPs suggest interaction of
AgNPs with the cell. The strongest cellular interaction with AgNPs seemed to occur at the
1.0 mg L-1; this had the broadest hyperspectral peak (Table 6).
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Table 6. Spectra maxima and full width half maximum of cell and AgNPs at each
exposure concentration for 12 hr.
AgNPs Exposure
Concentration (mg L-1)
0
0.1
1
3

Maximum Wavelength
(nm)
559
585
582
579

FWHM
219
210
252
152

From both the CytoViva images and hyperpectral data, it suggests that there is interaction
between the AgNPs and the cell.
A two sample t-test was performed to determine if there was a significant difference
between the FWHM at different exposure times and concentrations. When comparing the
2 hr and 4 hr exposure times, the p-value was determined to be 0.14 indicating no
signicant difference. At the 2 hr and 12 hr exposure times, the p-value was determined to
be 0.28, again indicating no significant difference. The p-value for the 4 hr and 12 hr
exposure times was determined to be 0.47 showing no sigificant difference.
Hyperspectral data and FWHM values for AgNP exposures at 1 and 3 mg L-1 were able
to be collected for 2, 4, and 12 hr exposure times. A two sample t-test was performed to
determine if there was any statistical significane between these FWHM values. The pvalue was found to be 0.09, indicating no siginicant difference between these FWHM
values at these exposure concentrations. Since the data is not signicantly different, a trend
cannot be determined from the FWHM data. However, the CytoViva otpical image data
suggests an interaction between the AgNPs and cell could be occuring.
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Figure 25. CytoViva optical images overlaid with fluorescence images of exposed Vero 76
cells to a) 0, b) 0.1, c) 1.0, and d) 3.0 mg L-1 for 24 hr. All cells were stained with 100 nM
Mito-tracker red dye prior to AgNP exposure. All scale bars are 25 µm.
Figure 25 displays the CytoViva optical images of cells superimposed on the
corresponding fluorescence images after the 24 hr exposure to various concentrations of
AgNPs. A similar trend was observed as in the 2, 4, and 12 hr exposures. The interaction
of the AgNPs increased as the time and concentration were increased. This was
confirmed by the hyperspectral data (Figure 26).
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Figure 26. Corresponding hyperspectral data of Vero 76 cells exposed to a) 1.0, and b)
3.0 mg L-1 of AgNPs for 24 hr.
The hyperspectral data from both 1.0 and 3.0 mg L-1 were observed to have to 2 peaks.
This may be occurring because of the AgNPs interaction with the cells are causing cell
death and contents leaking out. FWHM could not be calculated for these exposures.
3.4. Analysis of Exposed Vero 76 Cells by ICP-OES
During the mitochondrial isolation process, ten samples for each exposure (90 samples
total) were collected and analyzed by ICP-OES. Eleven samples fell above the limit of
detection (LOD), but only three samples were above the limit of quantification (LOQ)
(Table 3). The LOD is 5.0 µg L-1 and LOQ is 3.0 µg L-1.
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Table 7. Silver concentration in exposed AgNP samples taken during the mitochondrial
isolation process. Sample names are defined in Supporting Information Table S1.
AgNP Exposure
Concentration
(mg L-1)
Incubated DMEM w/AgNPs
0.1
Cytosol fraction
1
Other cellular components
1
PBS wash 1
1
Incubated DMEM w/AgNPs
1
Mitochondria pellet
1.5
Cytosol fraction
1.5
Other cellular components
1.5
DMEM supernatant 2
1.5
PBS wash 1
1.5
Incubated DMEM w/AgNPs
1.5
*Samples fell below the LOQ of 5 µg L-1.
Sample

Ag Concentration
(µg L-1)

Percentage
(%)

53*
17*
95*
72*
862
12*
92*
68*
51*
151
1161

53
2
10
7
86
1
6
5
3
10
77

The samples above the LOQ show that most of the AgNPs remained in incubated DMEM
w/AgNPs. At the 1 mg L-1 exposure, 86% of the AgNPs were found in the incubated
DMEM. At 1.5 mg L-1, 77% of the AgNPs remained in the incubated DMEM, while 10%
of the AgNPs remained in the PBS wash 1. Samples above the LOD show that AgNPs
are entering the cell, but the amount could not be report with accuracy. A repeated
measures ANOVA was run to determine if there were any significant differences between
the four AgNP exposure concentrations (0, 0.1, 1.0, and 1.5 mg L-1) and at the various
stages of the experiment ranging from sample 1 to sample 10. Since not all samples were
above the LOD, not every sample is represented for each experiment. A level of
significance of α = 0.05 was used to assess statistical significance and SAS version 9.4
was used for all analyses. Statistical analysis was run by the Statistics Consulting Center
at Wright State University. Descriptive statistics for ICP-OES analysis are in Table 8.
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Table 8. Descriptive statistics for ICP-OES analysis by concentration and sample. Sample
names defined in Supporting Information Table S1.
AgNP
Exposure
Concentration
(mg L-1)

0

0.1

1

1.5

Sample

N

Mean

Std
Dev

PBS wash 1
Media supernatant
Other cellular
components
Cytosol fraction
Mitochondria pellet
Incubated DMEM
w/AgNPs
Incubated DMEM
w/AgNPs
PBS wash 1
Other cellular
components
Cytosol fraction
Incubated DMEM
w/AgNPs
PBS wash 1
Media Supernatant
Other cellular
components
Cytosol fraction
Mitochondria pellet

6
3
9

63.83
63.88
129.2

27.87
28.51
28.07

29.33
36.44
65.95

108.12
93.36
164.79

3
3
9

70.03
67.88
151.65

7.59
17.79
14.99

63.61
49.9
130.25

78.4
85.48
176.46

9

206.2
3
38.85
61.39

875.35

1395.41

9
9

1124.4
5
173.88
202.33

109.16
139.54

244.59
279.78

6
9

110.37
1483.8

26.03
92.07

79.24
1353.51

148.49
1600.99

9
9
9

269.76
148.72
169.62

47.08
32.25
25.63

211.56
108.14
116.57

343.95
207.41
199.09

9
9

198.11
102.11

42.23
22.79

129.27
70.57

250.48
131.59

Minimum Maximum

From the descriptive statistics in Table 8, 45 comparisons of interest were made. Of those
45 comparisons, 31 compared the ICP-OES mean values between samples within the
same concentration, and 14 compared the ICP-OES mean values of the samples within
the same concentration. A stepdown Bonferroni multiple comparison procedure was
utilized in order to control the potential for type I error rate, this is when significance is
claimed, but there are none. A confidence level of 95 % at most was utilized, this was
calculated via Bonferroni multiple comparison procedure. These results are contained in
Supporting Information (Table S2).
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Samples within the AgNP exposure concentration 0 mg L-1, there was not adequate
evidence to suggest any significant differences among all comparisons (all p-values were
0.99). At AgNP exposure concentration 0.1 mg L-1, there was only one sample that was
above the LOD, therefore no comparisons between samples at this concentration could be
made.
Samples within AgNP exposure concentration 1.0 mg L-1, there is strong evidence
suggesting a significant mean difference between sample 1 and sample 2 (p-vale <
0.0001). A significant mean difference between sample 1 and sample 7, having a p-value
of < 0.001. There was also strong evidence suggesting there is a mean difference between
sample 1 and sample 8 (p-value < 0.0001). No other significant differences were
detected.
Samples within the AgNP exposure concentration 1.5 mg L-1, there was strong evidence
suggesting a significant mean difference between: sample 1 and sample 2, sample 1 and
sample 6, sample 1 and sample 7, sample 1 and sample 8, sample 1 and sample 10. All
comparisons with a significant mean difference had a p-value of < 0.0001. No other
significant differences were detected within the samples at this concentration.
The only comparison that could be made between different AgNP exposure
concentrations were with sample 1. There was strong evidence suggesting a significant
mean difference between sample 1 for the following concentrations: 0.1 and 1.0 mg L-1,
0.1 and 1.5 mg L-1, 1 and 1.5 mg L-1. Between AgNP exposure concentrations 0.1 and 1.0
mg L-1, the p-value was determined to be < 0.0001. The p-value between AgNP exposure
concentrations 0.1 and 1.5 mg L-1 was also < 0.0001. Lastly, between AgNP exposure
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concentrations 1.0 and 1.5 mg L-1, the p-value was determined to equal 0.0005. No other
significant differences were detected.
All significant differences detected involved sample 1, however, data for sample 1 at 0
mg L-1 was not reliable, therefore no conclusions could be drawn about it relative to other
samples at 0 mg L-1 or compared to other concentrations at sample 1. No conclusions
could be drawn at the AgNP exposure concentration 0.1 mg L-1 due to only sample 1 data
being above the LOD.
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4. Conclusions
From CytoViva images, it was observed as concentration of AgNPs and time increased,
more cell death occurred, which correlates to the proposed hypothesis. This could be
clearly seen by the morphological changes to cell shape as the time and concentration of
AgNPs was increased. From the hyperspectral data collected of exposed cells at various
concentrations, it suggests that there is interaction between the cell and AgNPs. In the
future, implementing the 3-D camera on CytoViva would help determine if the AgNPs
are interacting with the cell wall and/or have entered the cytosol. This would give insight
into the possible mechanism of how AgNPs are entering the cell and causing cell death.
From ICP-OES data, it was determined that there were significant mean differences
between some samples within the same concentration and between sample 1 at different
exposure concentrations. It can be concluded that AgNPs did enter the mitochondria of
the cells, however, the amount could not be quantified. To produce more accurate results,
concentrations used for exposures need to be increased and the exposure time should be
increased as well to increase the chances of AgNPs entering the mitochondria. The
sample preparation of biological samples for ICP-OES should also be adjusted to a
smaller dilution factor.
The AgNP synthesis could be optimized for a higher yield. Perhaps less starch could be
used, eliminating the purification via centrifugated step. Also, doing a large batch-wise
process, larger surface area TFF filter, and a peristaltic pump would increase yield and
efficiency. It was observed that the colloid became gel-like when the excess starch was
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not removed before filtration of the original colloid. A future application of starchedcapped AgNP synthesis, could be to use this gel-like colloid in the medical field, perhaps
in a burn gel.
The main aim of this study was to determine if AgNPs were entering the mitochondria of
Vero 76 cells, quantify the total silver content, and look at AgNP distribution within the
cell. It was determined AgNPs are entering the cell, but the ICP-OES signal fell below
the LOQ. To quantify the total silver content within these biological matrices, the
exposure concentrations of AgNPs should be increased and the dilution factor used in
sample preparation decreased.
Future Raman spectroscopy experiments should be performed to investigate the
mechanism of AgNP formation and of AgNP-cellular interaction. CytoViva 3-D imaging
should be employed to give insight if the AgNP is interacting with the cellular wall
and/or components inside the cell. Lastly, MTT and ROS assays should also be
performed to investigate cellular metabolic activity and the cause of cell death.
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6. Supporting Information
Table S1. List of sample names for each step of the mitochondrial isolation assay.
Sample Number
1
2
3
4
5
6
7
8
9
10

Sample Name
Incubated DMEM w/AgNPs
PBS wash 1
PBS wash 2
PBS wash 3
Media supernatant 1
Media supernatant 2
Other Cellular components
Cytosol fraction
Mitochondrial pellet wash
Mitochondria pellet

Table S2. Statistical summary of the stepdown Bonferroni procedure for ICP-OES
measurements utilizing a 95% confidence level.
Comparison (mg L-1)
Concentration 0: Sample 2 - 6
Concentration 0: Sample 2 - 7
Concentration 0: Sample 2 - 8
Concentration 0: Sample 2 - 10
Concentration 0: Sample 6 - 7
Concentration 0: Sample 6 - 8
Concentration 0: Sample 6 - 10
Concentration 0: Sample 7 - 8
Concentration 0: Sample 7 - 10
Concentration 0: Sample 8 - 10

Estimate
-0.05
-65.37
-6.2
-4.05
-65.32
-6.15
-4
59.17
61.32
2.15

Standard Error
99.38
74.07
99.38
99.38
93.7
114.75
114.75
93.7
93.7
114.75

p - value
0.99
0.99
0.99
0.99
0.99
0.99
0.99
0.99
0.99
0.99

Concentration 1: Sample 1 - 2
Concentration 1: Sample 1 - 7
Concentration 1: Sample 1 - 8
Concentration 1: Sample 2 - 7
Concentration 1: Sample 2 - 8
Concentration 1: Sample 7 - 8

950.58
922.12
1014.08
-28.45
63.51
91.96

66.25
66.25
74.07
66.25
74.07
74.07

< 0.0001
< 0.0001
< 0.0001
0.99
0.99
0.99
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Concentration 1.5: Sample 1 - 2
Concentration 1.5: Sample 1 - 6
Concentration 1.5: Sample 1 - 7
Concentration 1.5: Sample 1 - 8
Concentration 1.5: Sample 1 - 10
Concentration 1.5: Sample 2 - 6
Concentration 1.5: Sample 2 - 7
Concentration 1.5: Sample 2 - 8
Concentration 1.5: Sample 2 - 10
Concentration 1.5: Sample 6 - 7
Concentration 1.5: Sample 6 - 8
Concentration 1.5: Sample 6 - 10
Concentration 1.5: Sample 7 - 10
Concentration 1.5: Sample 7 - 8
Concentration 1.5: Sample 8 - 10

1214.04
1335.08
1314.18
1285.7
1381.7
121.04
100.14
71.66
167.65
-20.9
-49.38
46.61
-28.48
67.52
96

66.25
66.25
66.25
66.25
66.25
66.25
66.25
66.25
66.25
66.25
66.25
66.25
66.25
66.25
66.25

< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
0.99
0.99
0.99
0.62
0.99
0.99
0.99
0.99
0.99
0.99

Sample 1: 0.1 - 1
Sample 1: 0.1 - 1.5
Sample 1: 1 - 1.5
Sample 2: 0 - 1
Sample 2: 0 - 1.5
Sample 2: 1 - 1.5
Sample 6: 0 - 1.5
Sample 7: 0 - 1
Sample 7: 0 - 1.5
Sample 7: 1 - 1.5
Sample 8: 0 - 1
Sample 8: 0 - 1.5
Sample 8: 1 - 1.5
Sample 10: 0 - 1.5

-972.8
-1332.15
-359.35
-110
-205.88
-95.89
-19.52
-132.3
-99.59
32.71
-40.34
-128.07
-87.74
-34.23

66.25
66.25
66.25
93.7
93.7
66.25
66.25
93.7
93.7
66.25
99.38
93.7
74.07
93.7

< 0.0001
< 0.0001
0.0005
0.99
0.99
0.99
0.99
0.99
0.99
0.9
0.99
0.99
0.99
0.99
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